Coronary microvascular disease
Conditions
Interventions
Experimental Group:Acupuncture combined with conventional Western medical treatment
Control Group:Sham acupuncture combined with conventional Western medication.
Sponsors
Guang'anmen Hospital of the Chinese Academy of Traditional Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. 18 years old = age = 80 years old, gender; 2. Meets the Western medical diagnostic criteria for CMVD; 3. Chinese medical diagnosis meets the criteria for qi deficiency and blood stasis syndrome; 4. Drug regimen has been relatively stable in the past month, and willing to cooperate with follow-up and acupuncture; 5. Willing to accept random grouping, understands the study content, and willing to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Acute coronary syndrome or revascularization within 3 months; significant valvular disease, cardiomyopathy, or heart failure (NYHA III–IV); 2. Severe hepatic and renal insufficiency, active bleeding, or coagulation disorders; 3. Pregnancy or breastfeeding; 4. Contraindications to acupuncture, such as local infection, severe skin disease, or implanted devices in the chest located in a dangerous area for acupuncture point selection; 5. Allergy or contraindications to basic treatment drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall clinical efficacy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Seattle Angina Questionnaire Scoring;Europe Quality of Life 5dimensions 5 Levels Scoring;Angina Frequency;blood indicators;TCM Syndrome Score; | — |
Countries
China
Contacts
Public ContactZhang Li Mei, Meng Ling Hao
Guang'anmen Hospital of the Chinese Academy of Traditional Medicine
Outcome results
None listed